Respiratory Diseases Stocks List Ranked for 2024 |

Respiratory Diseases ETFs
Recent Respiratory Diseases News

Symbol	Grade	Name	% Change
AZN	A	Astrazeneca PLC	0.47
MRK	A	Merck & Company, Inc.	0.01
TBPH	B	Theravance Biopharma, Inc.	-0.33
SPRY	B	ARS Pharmaceuticals, Inc.	-4.00
EHAB	B	Enhabit, Inc.	-0.49
ALVO	C	Alvotech	0.93
VMD	C	Viemed Healthcare, Inc.	-0.74
SVRA	D	Savara, Inc.	-9.17
SMLR	D	Semler Scientific, Inc.	-2.18
WINT	F	Windtree Therapeutics, Inc.	-7.57

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

Symbol	Grade	Name	Weight
PPH	C	Market Vectors Pharmaceutical ETF	11.83
MEDX	F	Horizon Kinetics Medical ETF	9.77
FTXH	C	First Trust Nasdaq Pharmaceuticals ETF	7.51
XLV	C	SPDR Select Sector Fund - Health Care	6.19
PJP	C	PowerShares Dynamic Pharmaceuticals	6.0

View all Respiratory Diseases ETFs...

Compare ETFs

Compare MEDX to PJP Compare MEDX to XLV Compare PPH to MEDX

Respiratory Diseases Stocks Recent News

Date	Stock	Title
Feb 7	VMD	(Exclusive) Stocks To Watch, PRO+ Edition
Apr 24	MRK	4 Large Drug Stocks to Hold on to Amid Industry Challenges
Apr 24	MRK	Merck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growth
Apr 24	AZN	AstraZeneca: What The Market's Missing
Apr 24	ALVO	Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Apr 24	AZN	Liquid biopsy firm Angle signs new commercial agreement with AstraZeneca
Apr 23	WINT	(WINT) - Analyzing Windtree Therapeutics's Short Interest
Apr 23	AZN	AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Apr 23	SMLR	Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Apr 23	MRK	Here’s Why Merck & Co. (MRK) Outperformed in Q1
Apr 22	AZN	Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics
Apr 22	MRK	How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Apr 22	MRK	10 Best Performing Biotech ETFs in 2024
Apr 22	AZN	With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Apr 22	AZN	Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Apr 21	MRK	Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 21	AZN	Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 21	AZN	11 Best Low Price Pharma Stocks To Invest In
Apr 21	MRK	Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%
Apr 19	AZN	Looking At AstraZeneca's Recent Unusual Options Activity

Respiratory Diseases: Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

Browse All Tags